BIOMARIN PHARMACEUTICAL INC financial data

Symbol
BMRN on Nasdaq
Location
Novato, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 525% % 46%
Quick Ratio 185% % 36%
Debt-to-equity 24% % -18%
Return On Equity 5.8% % -27%
Return On Assets 4.7% % -24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 192,323,359 shares 0.29%
Common Stock, Shares, Outstanding 192,300,101 shares 0.81%
Entity Public Float $6,700,000,000 USD -23%
Common Stock, Value, Issued $192,000 USD 0.52%
Weighted Average Number of Shares Outstanding, Basic 191,787,000 shares 0.93%
Weighted Average Number of Shares Outstanding, Diluted 197,394,000 shares 0.35%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,221,253,000 USD 13%
Cost of Revenue $717,442,000 USD 24%
Research and Development Expense $921,930,000 USD 23%
Costs and Expenses $2,811,775,000 USD 19%
Operating Income (Loss) $409,478,000 USD -15%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $482,480,000 USD -11%
Income Tax Expense (Benefit) $133,579,000 USD 16%
Net Income (Loss) Attributable to Parent $348,901,000 USD -18%
Earnings Per Share, Basic 1.82 USD/shares -19%
Earnings Per Share, Diluted 1.8 USD/shares -19%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,311,679,000 USD 39%
Accounts Receivable, after Allowance for Credit Loss, Current $908,214,000 USD 37%
Inventory, Net $1,298,883,000 USD 5.4%
Other Assets, Current $185,784,000 USD -7.8%
Assets, Current $3,953,490,000 USD 22%
Deferred Income Tax Assets, Net $1,508,697,000 USD 1.3%
Property, Plant and Equipment, Net $952,508,000 USD -8.7%
Operating Lease, Right-of-Use Asset $35,243,000 USD 23%
Intangible Assets, Net (Excluding Goodwill) $213,837,000 USD -16%
Goodwill $196,199,000 USD 0%
Other Assets, Noncurrent $277,049,000 USD 10%
Assets $7,594,022,000 USD 8.7%
Employee-related Liabilities, Current $219,422,000 USD 8.4%
Contract with Customer, Liability, Current $1,369,000 USD -70%
Liabilities, Current $759,031,000 USD 25%
Operating Lease, Liability, Noncurrent $36,576,000 USD 20%
Other Liabilities, Noncurrent $150,816,000 USD 17%
Liabilities $1,507,023,000 USD 13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $13,473,000 USD -122%
Retained Earnings (Accumulated Deficit) $154,206,000 USD
Stockholders' Equity Attributable to Parent $6,086,999,000 USD 7.6%
Liabilities and Equity $7,594,022,000 USD 8.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $174,394,000 USD 271%
Net Cash Provided by (Used in) Financing Activities $38,779,000 USD 9.4%
Net Cash Provided by (Used in) Investing Activities $28,238,000 USD -98%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 192,300,101 shares 0.81%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $105,961,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,311,679,000 USD 39%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $181,743,000 USD 44%
Operating Lease, Liability $45,145,000 USD 20%
Depreciation $48,500,000 USD 4.1%
Payments to Acquire Property, Plant, and Equipment $16,768,000 USD -36%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $273,775,000 USD -47%
Lessee, Operating Lease, Liability, to be Paid $56,652,000 USD 21%
Property, Plant and Equipment, Gross $2,026,813,000 USD 4.8%
Operating Lease, Liability, Current $8,569,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,355,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year One $10,066,000 USD 10%
Operating Lease, Weighted Average Discount Rate, Percent 0.062 pure 1.6%
Deferred Income Tax Expense (Benefit) $28,429,000 USD 9875%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,507,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,592,000 USD 24%
Deferred Tax Assets, Operating Loss Carryforwards $105,642,000 USD 468%
Unrecognized Tax Benefits $380,886,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,332,000 USD 1.6%
Amortization of Intangible Assets $19,386,000 USD -55%
Depreciation, Depletion and Amortization $22,069,000 USD -19%
Deferred Tax Assets, Net of Valuation Allowance $1,541,917,000 USD -0.62%
Share-based Payment Arrangement, Expense $181,409,000 USD -10%
Interest Expense $17,179,000 USD 8.3%